Advancing Diversity in Oncology Clinical Trials: 5 Key Insights from Clinical Trial Sites
|
At Precision for Medicine, our Clinical Research Associates (CRAs) serve as the linchpin between trials and triumph. Grounded in a philosophy that intertwines the safety of patients with the sanctity of data, our CRAs embody a suite of principles to diligently advance your trial’s objectives. Through proactive site management, effective communication, and unwavering compliance, they ensure each monitored site resonates with the rigor and care that define Precision’s approach to clinical oversight. Our commitment extends beyond standard practices, nurturing a culture of training and mentorship to foster growth and excellence in clinical monitoring.
Patient Safety First
Proactive Site Management
Effective Communication
Compliance & Protocol Adherence
Training & Mentorship
Data Integrity Focus
At Precision, we embrace a data-centric approach to Risk-Based Monitoring (RBM). By identifying the critical data and how it is collected, we identify potential risks and develop robust strategies to proactively secure the data, enabling our CRAs to focus their efforts where it's most needed. This method not only streamlines the monitoring process but also allocates resources more effectively so that critical trial aspects receive the attention required without undue expenditure. Utilizing advanced analytical tools, such as Precision's Clarity alongside industry-standard platforms like Medidata CTMS, our RBM strategies are designed to safeguard the integrity of your trial data while optimizing the monitoring workload.
Precision's Centralized Monitoring team leverages our proprietary Clarity clinical intelligence suite to provide a comprehensive review of aggregate data, identifying outliers, trends, and safety signals. Our strategic approach reduces the need for frequent onsite visits by utilizing powerful analytics and dynamic data visualization, augmented by our cross-functional and integrated data review process. This enables Precision to optimize site performance and data integrity, supporting a streamlined SDV/SDR strategy.
The emphasis on patient centricity and decentralized clinical trials (DCTs) is more than a trend—it’s a transformative shift towards respecting and accommodating the real-world contexts of patients and their caregivers. Precision for Medicine champions this shift, drawing from our rich experience across oncology and rare diseases, to design trials that are as considerate as they are scientifically rigorous. By thoughtfully incorporating patient lifestyles and symptoms into trial designs, we ensure participation is not only viable but also meaningful for patients and caregivers alike. Our strategies embody our commitment to making trials more patient-centric, from pediatric to adult populations, offering a smoother and more inclusive research journey. Discover how our innovative approaches in patient recruitment (HL) and DCTs (HL) are making a difference.
We recognize the patient journey throughout the development process. Our mission is to assist our partners in delivering innovative treatments to patients. Leverage our deep expertise in these therapeutic areas to advance your clinical goals.
Stay at the forefront of research with Precision’s blog, featuring key updates and insights on clinical monitoring, case studies, and more
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.
Award-winning CRO with deep oncology and rare disease expertise
Exceptional translational and biomarker sciences with global central lab services
Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.
See how our strategic Clinical Monitoring approach accelerates your path to pivotal trial milestones and beyond.